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Corrigenda 
FEBS 13991 
YGEI is a yeast homologue of Escherichia cot? grpE and is required for maintenance of mitochondrial functions 
Eri Ikeda, Satoshi Yoshida, Hiroshi Mitsuzawa, Isao Uno, Akio Toh-e 
FEBS Letters 339 (I 994) 265-268 
Note added in proof 
We found an error in our nucleotide sequence of the ZTGEl gene and corrected it after this paper had been accepted 
for publication. We would not have done a con~~ative experiment on the YGEI sequence unless we had known the 
sequencing result of the same gene done by Luca Bolliger, Olivier Deloche, Benjamin S. Glick, Costa Georgopoulos, 
Paul JenS, Nafsika Kronidou, Martin Horst, Nobuhiro Mo~shima and Gottfried Schatz (EMBO J. in press), that was 
supplied to us as unpublished information. We regret not mentioning this fact in our paper. 
FEBS 13988 
Site-specific label&g of the oligosaccharide chains of antibodies 
Uwe Schwarz, Gerd Wunderlich, Reinhard Brossmer 
FEBS Letters 337 (1994) 213-216 
On p. 213, section 2.2., the first sentence shoutd have read: 
The standard reaction mixture contained 1 pug CMP-9-deoxy-9-salizoyI-NeuAc in 50 mM phosphate buffer pH 7.0. 
On p_ 214, section 2.4., paragraph 2, the second sentence should have read: 
For transfer of 14C labeled NeuAc 50 pug IgG, ..+. 
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On p. 214, section 2.4., the last paragraph should have read: 
For the transfer of the monoiodo derivative of CMP-9-deoxy-9-salizoyl-Neck 100 pg IgG in 100 ~1 15 mM 
phosphate buffer, pH 7.0, 10 mU ol-2,6-ST (5 ~1) and 100 ,DI of the HPLC-fraction containing the radioactive substance 
were incubated. The reaction mixture for the transfer of the diiodo derivative consisted of 100 ,ug IgG in 100&l 15 mM 
phosphate buffer pH 7.0, 40 mU as-2,6-ST (20 ~1) and 200 ,ul of the HPLC-fraction containing the diiodo derivative. 
On p. 214, the legend to Fig. 4 should have read: 
o, 1 ,ug iodogen; q , 10 ,ug iodogen. 
On p. 215, right column, the first line shoutd have read: 
*.. the reaction with 1 or 10 pg iodogen was very fast . . . . 
On p. 215, right column, line 3 shozdd have read: 
For carrier added iodination we used vials with 100 pg iodogen, 
FEBS 13989 
Irsogladine is a potent inhibitor of angiogenesis 
Yasufumi Sato, Akio Morimoto, Akira Kiue, Kazuki Okamura, Ryoji Hamanaka, Kimitoshi Kohno, Michihiko 
Kuwano, Toshiie Sakata 
FEBS Letters 322 (1993) 155-158 
The structure of Irsogladine presented in Fig. 1 was not correct. The correct structure is presented below. 
Cl 
HCCOOH 
- Ii 
HCCOOH 
NHz 
(C9H7ClzNs * CM3404 ) 
Fig. 1. The structure of Irsogladine. 
